Lite Strategy, Inc. Deferred Tax Liabilities, Unrealized Currency Transaction Gains
Lite Strategy, Inc. (LITS) had Deferred Tax Liabilities, Unrealized Currency Transaction Gains of $13.00 thousand as of 2011-06-30, per its 10-K filed 2012-09-18.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains · last filed 2012-09-18
- 2011-06-30: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $13.00K.
| Period end | Deferred Tax Liabilities, Unrealized Currency Transaction Gains |
|---|---|
| 2011-06-30 | $13.00K 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |